30 October 2023 - New rules for the reimbursement of orphan drugs and other unlisted medicines will become effective in Switzerland after 1 January 2024. 

In principle, only medicines on an exhaustive list (i.e. the list of specialities) are reimbursed. However, in order to give patients access to vital therapies, health insurers must also the cover costs of treatment in exceptional cases, particularly in cases of hardship. This case by care reimbursement is particularly important for orphan drugs.

Read Lexology article